Click to view full infographic
It has been an exciting few years for the biotech sector, but huge peaks in investment in 2021were replaced by funding falls in Q1 of 2022. In this infographic, GOLD reflects on the evolution of the biotech sector since 2016, tracking rising revenues, investment cuts and drugs that are making it to market despite ongoing uncertainty and turbulence.
